ScienceDaily: Health & Medicine News |
- Combining targeted drug with chemotherapy offers longer life to b-cell cancer patients
- Scale to stratify magnitude of clinical benefit of anticancer medicines
- Practice-changing study offers new option for tough breast cancer cases
- Targeted drug can ‘diminish the suffering’ of myelofibrosis
- Removing more tissue during breast cancer surgery reduces by half the need for second procedure
- Doctors' checklist could help decrease length of COPD patients' hospital stay
- Altered pain processing in patients with cognitive impairment
- Many UK patients with gonorrhea prescribed outdated antibiotics
- End European agreements with tobacco industry designed to curb smuggling, urge experts
Combining targeted drug with chemotherapy offers longer life to b-cell cancer patients Posted: 30 May 2015 07:25 AM PDT Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia or small lymphocytic lymphoma, an interim analysis has closed the international HELIOS phase III clinical trial. |
Scale to stratify magnitude of clinical benefit of anticancer medicines Posted: 30 May 2015 07:25 AM PDT ESMO, the European Society for Medical Oncology, has announced the publication of the ESMO Magnitude of Clinical Benefit Scale, a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients. |
Practice-changing study offers new option for tough breast cancer cases Posted: 30 May 2015 07:22 AM PDT A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer. |
Targeted drug can ‘diminish the suffering’ of myelofibrosis Posted: 30 May 2015 07:22 AM PDT Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent. |
Removing more tissue during breast cancer surgery reduces by half the need for second procedure Posted: 30 May 2015 07:22 AM PDT Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. |
Doctors' checklist could help decrease length of COPD patients' hospital stay Posted: 29 May 2015 06:45 PM PDT Patients with worsening chronic obstructive pulmonary disease spend less time in hospital when their doctors manage their care by using a checklist of steps called order sets. |
Altered pain processing in patients with cognitive impairment Posted: 29 May 2015 10:15 AM PDT People with dementia and other forms of cognitive impairment (CI) have altered responses to pain, with many conditions associated with increased pain sensitivity, concludes a new research review. |
Many UK patients with gonorrhea prescribed outdated antibiotics Posted: 29 May 2015 05:35 AM PDT Many UK patients with gonorrhea are being prescribed antibiotics that are no longer recommended for treating the infection by their family doctor, reveals research published in the online journal BMJ Open. |
End European agreements with tobacco industry designed to curb smuggling, urge experts Posted: 29 May 2015 05:35 AM PDT The agreements drawn up between the European Union and the four major transnational tobacco companies, to crack down on cigarette smuggling and recoup lost tax revenues, are failing to meet their stated aims, concludes research. |
You are subscribed to email updates from Health & Medicine News -- ScienceDaily To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
ليست هناك تعليقات:
إرسال تعليق